Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Gross Margin (2020 - 2025)

Historic Gross Margin for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to 72.4%.

  • GeneDx Holdings' Gross Margin rose 101900.0% to 72.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 69.65%, marking a year-over-year increase of 101700.0%. This contributed to the annual value of 63.64% for FY2024, which is 192100.0% up from last year.
  • GeneDx Holdings' Gross Margin amounted to 72.4% in Q3 2025, which was up 101900.0% from 69.04% recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Gross Margin registered a high of 72.4% during Q3 2025, and its lowest value of 81.83% during Q2 2022.
  • Its 5-year average for Gross Margin is 27.4%, with a median of 38.51% in 2023.
  • In the last 5 years, GeneDx Holdings' Gross Margin crashed by -793600bps in 2022 and then skyrocketed by 1203400bps in 2023.
  • Over the past 5 years, GeneDx Holdings' Gross Margin (Quarter) stood at 4.85% in 2021, then tumbled by -448bps to 26.61% in 2022, then skyrocketed by 301bps to 53.56% in 2023, then rose by 29bps to 69.22% in 2024, then increased by 5bps to 72.4% in 2025.
  • Its last three reported values are 72.4% in Q3 2025, 69.04% for Q2 2025, and 67.13% during Q1 2025.